Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Amaravadi

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cancer Biology & Therapy|November 11, 2009
Autophagy can contribute to cell death when combining targeted therapyRavi Amaravadi
Cancer Discovery|August 6, 2014
Mouse models address key concerns regarding autophagy inhibition in cancer therapyRavi Amaravadi, Jayanta Debnath
The Journal of Clinical Investigation|October 4, 2005
The survival kinases Akt and Pim as potential pharmacological targetsRavi Amaravadi, Craig B Thompson
Genes & Development|September 25, 2016
Recent insights into the function of autophagy in cancerRavi Amaravadi, Alec C Kimmelman, Eileen White
Pigment Cell & Melanoma Research|August 20, 2008
Effectively targeting BRAF in melanoma: a formidable challengeLeslie A Fecher, Ravi Amaravadi, Lynn M Schuchter
Autophagy|April 2, 2014
Autophagy researchersRavi Amaravadi, Maureen E Murphy, Thierry Soldati, et al.
Pigment Cell & Melanoma Research|October 30, 2023
20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma researchRavi Amaravadi, Andrew Aplin, Meenhard Herlyn, et al.
Journal of Orthopaedic Case Reports|July 9, 2021
A Case of Tumor-Induced Osteomalacia: Finding the Culprit Acetabular Tumor and Successful Resection with a Novel Hip Joint-Preserving SurgeryChristie G Turin, Robert J Wilson, Ciera Mangone, et al.
Annals of Surgical Oncology|October 8, 2025
ASO Visual Abstract: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic MelanomaNeha Shafique, Mohammad Saad Farooq, Valentina Mattfeld, et al.
Annals of Surgical Oncology|September 12, 2025
Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic MelanomaNeha Shafique, Mohammad Saad Farooq, Valentina Mattfeld, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|November 11, 2009
Autophagy can contribute to cell death when combining targeted therapyRavi Amaravadi
Cancer Discovery|August 6, 2014
Mouse models address key concerns regarding autophagy inhibition in cancer therapyRavi Amaravadi, Jayanta Debnath
The Journal of Clinical Investigation|October 4, 2005
The survival kinases Akt and Pim as potential pharmacological targetsRavi Amaravadi, Craig B Thompson
Genes & Development|September 25, 2016
Recent insights into the function of autophagy in cancerRavi Amaravadi, Alec C Kimmelman, Eileen White
Pigment Cell & Melanoma Research|August 20, 2008
Effectively targeting BRAF in melanoma: a formidable challengeLeslie A Fecher, Ravi Amaravadi, Lynn M Schuchter
Autophagy|April 2, 2014
Autophagy researchersRavi Amaravadi, Maureen E Murphy, Thierry Soldati, et al.
Pigment Cell & Melanoma Research|October 30, 2023
20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma researchRavi Amaravadi, Andrew Aplin, Meenhard Herlyn, et al.
Journal of Orthopaedic Case Reports|July 9, 2021
A Case of Tumor-Induced Osteomalacia: Finding the Culprit Acetabular Tumor and Successful Resection with a Novel Hip Joint-Preserving SurgeryChristie G Turin, Robert J Wilson, Ciera Mangone, et al.
Annals of Surgical Oncology|October 8, 2025
ASO Visual Abstract: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic MelanomaNeha Shafique, Mohammad Saad Farooq, Valentina Mattfeld, et al.
Annals of Surgical Oncology|September 12, 2025
Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic MelanomaNeha Shafique, Mohammad Saad Farooq, Valentina Mattfeld, et al.
Pageof 4